The ecology of cancer differentiation therapy

Ricard Solé1, Guim Aguadé-Gorgorió2

  • 1ICREA-Complex Systems Lab, Universitat Pompeu Fabra, 08003 Barcelona, Catalonia, Spain; Institut de Biologia Evolutiva (CSIC-UPF), Psg Maritim Barceloneta, 37, 08003 Barcelona, Catalonia, Spain; Santa Fe Institute, 1399 Hyde Park Road, Santa Fe NM 87501, USA.

Insights

Differentiation therapy (DTH) shows promise for cancer treatment by promoting cell specialization. Mathematical models, inspired by ecological principles, offer insights into DTH effectiveness, particularly for solid tumors and cancer stem cells.

Area of Science:

  • Oncology
  • Mathematical Biology
  • Cancer Research

Background:

  • Differentiation therapy (DTH) is an emerging cancer treatment strategy.
  • Tumors often feature poorly differentiated cells lacking normal tissue functions.
  • DTH has shown success in certain cancers like acute promyelocytic leukemia (APL).

Purpose of the Study:

  • To develop a mathematical framework for understanding differentiation therapy (DTH).
  • To explore DTH effectiveness in solid tumors using ecological models.
  • To investigate the role of cancer stem cells (CSCs) and niche specificity in DTH resistance.

Main Methods:

  • Utilized a mathematical framework based on an ecological model of habitat loss.
  • Applied a hierarchical model incorporating cancer stem cells (CSCs).
  • Analyzed clinical and in vitro outcomes of DTH.

Main Results:

  • The ecological model successfully accounts for observed DTH outcomes.
  • The framework provides insights into potential DTH design strategies.
  • Niche specificity was highlighted as a key factor in CSC resistance to DTH.

Conclusions:

  • Metapopulation ecology principles can inform the development of DTH.
  • The mathematical framework aids in understanding and overcoming DTH challenges.
  • Ecological modeling offers valuable perspectives for advancing cancer differentiation therapy.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
888
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.3K